Trial Search Results
18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation
The investigators will evaluate the detection of cardiac sarcoidosis or inflammation using 18F-FSPG PET/MRI.
Stanford is currently accepting patients for this trial.
Lead Sponsor:
Stanford University
Collaborator: GE Healthcare
Stanford Investigator(s):
Intervention(s):
- Drug: 18F-FSPG
Phase:
Phase 2
Eligibility
Inclusion Criteria:
- Patient is ≥ 18 years old at the time of the scan
- Patient with known or suspected cardiac sarcoidosis.
- Patient is capable of complying with study procedures
- Patient can remain still for duration of imaging procedure
Exclusion Criteria:
- Patient is pregnant or nursing
- Metallic implants (contraindicated for MRI)
- History of renal insufficiency (only for MRI contrast administration)
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Andrea Otte, DPT
650-736-4183
Recruiting